Dr. Aditi Bhatt
Surgical Oncologist
Peritoneal Malignancies
MBBS, MS, MCh Surgical Oncology (GCRI, Ahmedabad)
- Experience
- 15+ years
- Speaks
- English · Hindi
Cancers treated
- Gynaecological
- Gastrointestinal
About Dr. Aditi Bhatt
Dr. Aditi Bhatt is a surgical oncologist who specialises in peritoneal cancers, which start in or spread to the lining of the abdomen. Her work covers pseudomyxoma peritonei and peritoneal spread from colorectal, ovarian and stomach cancer. For these cancers she performs cytoreductive surgery with HIPEC, in which visible tumour is removed and the abdomen is then washed with heated chemotherapy. She also performs PIPAC, which delivers chemotherapy to the abdomen as a fine spray. In more than 15 years of practice, she has performed over 5,000 surgeries. She works with patients through treatment and afterwards, to help them return to everyday life.
Treatments offered
Peritoneal & HIPEC
Gynaecological
- Ovarian cancer surgery
Gastrointestinal
- Colorectal cancer surgery
- Stomach cancer surgery
Career
- SSO × EPIC Hospital, AhmedabadSenior Consultant, Surgical Oncology · 2026–Present
- KD Hospital, AhmedabadSenior Consultant, Surgical Oncology · 2023–Present
- Shalby Cancer and Research Institute, AhmedabadSenior Consultant, Surgical Oncology · 2024–2026
- Zydus Hospital, AhmedabadConsultant, Surgical Oncology · 2017–2023
- Fortis Hospital, BangaloreConsultant, Surgical Oncology · 2013–2017
- HCG Bangalore Institute of OncologyConsultant, Surgical Oncology · 2010–2013
- Mazumdar Shaw Cancer Centre, Narayana Health City, BangaloreConsultant, Surgical Oncology · 2009–2010
Education & Training
- MCh Surgical OncologyGujarat Cancer & Research Institute, Ahmedabad · 2009
- MS General SurgeryB.J. Medical College, Ahmedabad · 2005
- MBBSB.J. Medical College, Ahmedabad · 2002
- Fellowship, CRS & HIPECInstitut Gustave Roussy, Paris
Research & Publications
See publications on PubMed (opens in a new tab)
Reviews & guidelines
- 2026Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensus (opens in a new tab)Lancet Oncol
- 2026PSOGI consensus on minimally invasive surgery for peritoneal surface malignancy (opens in a new tab)Br J Surg
- 2026The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Management of Advanced Epithelial Ovarian Cancer (opens in a new tab)Indian J Surg Oncol
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Gastric Cancer Peritoneal Metastases (opens in a new tab)Indian J Surg Oncol
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies: General Principles of Cytoreductive Surgery and Technical Considerations (opens in a new tab)Indian J Surg Oncol
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei (opens in a new tab)Indian J Surg Oncol
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Minimally Invasive Surgery for Peritoneal Malignancies (opens in a new tab)Indian J Surg Oncol
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Diagnosis and Management of Peritoneal Mesothelioma (opens in a new tab)Indian J Surg Oncol
- 2025Cytoreductive surgery for colorectal peritoneal metastasis in the era modern systemic therapies: a systematic review and meta-analysis of survival outcomes (opens in a new tab)Int J Colorectal Dis
- 2025Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation (opens in a new tab)J Surg Oncol
- 2025Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus (opens in a new tab)Br J Surg
- 2025Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries (opens in a new tab)Br J Surg
- 2025The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Methodology (opens in a new tab)Indian J Surg Oncol
- 2025The Mitomycin versus Oxaliplatin debate on HIPEC in colorectal cancers - An updated systematic review and Meta-analysis (opens in a new tab)Eur J Surg Oncol
- 2025INDEPSO-ISPSM consensus on peritoneal malignancies - Enhanced recovery after surgery in cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC) (opens in a new tab)Gynecol Oncol Rep
- 2024Do all patients that undergo a 'complete' secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it? (opens in a new tab)Pleura Peritoneum
- 2024INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases (opens in a new tab)JCO Glob Oncol
- 2024Review of 2022 PSOGI/RENAPE Consensus on HIPEC (opens in a new tab)J Surg Oncol
- 2024Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A systematic review (opens in a new tab)Eur J Surg Oncol
- 2024Two-stage cytoreductive surgery for 'extensive' pseudomyxoma peritonei: A legitimate alternative or salvage strategy? (opens in a new tab)Eur J Surg Oncol
- 2023The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer (opens in a new tab)Ann Surg Oncol
- 2023Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review (opens in a new tab)Indian J Surg Oncol
- 2023Rare Variants of Malignant Peritoneal Mesothelioma: a Literature Review (opens in a new tab)Indian J Surg Oncol
- 2023The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology (opens in a new tab)Ann Surg Oncol
- 2022Advances in the management of peritoneal malignancies (opens in a new tab)Nat Rev Clin Oncol
- 2022Hyperthermic Intraperitoneal Chemotherapy in the Treatment Armamentarium of Epithelial Ovarian Cancer: Time to End the Dichotomy (opens in a new tab)Visc Med
- 2021Primary and metastatic peritoneal surface malignancies (opens in a new tab)Nat Rev Dis Primers
- 2021HIPEC Methodology and Regimens: The Need for an Expert Consensus (opens in a new tab)Ann Surg Oncol
- 2020Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide (opens in a new tab)Indian J Surg Oncol
- 2020Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction (opens in a new tab)Ann Surg Oncol
- 2016Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy (opens in a new tab)Indian J Surg Oncol
- 2016The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review (opens in a new tab)Indian J Surg Oncol
- 2016Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer (opens in a new tab)Indian J Surg Oncol
- 2016Cytoreductive Surgery and Peritonectomy Procedures (opens in a new tab)Indian J Surg Oncol
Led by Dr. Bhatt
- 2026Right subphrenic peritonectomy procedure without initial liver mobilization to facilitate complete macroscopic resection of tumor in advanced tubo-ovarian carcinoma (opens in a new tab)Int J Gynecol Cancer
- 2026Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients (opens in a new tab)Eur J Surg Oncol
- 2026Parietal and visceral peritonectomy procedures for preservation of the rectosigmoid colon during interval cytoreductive surgery (opens in a new tab)Int J Gynecol Cancer
- 2026Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis (opens in a new tab)J Surg Oncol
- 2026Prevention of Acute Kidney Injury Following CRS and HIPEC: One Strategy is Not Enough (opens in a new tab)Ann Surg Oncol
- 2026MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study (opens in a new tab)Ann Surg Oncol
- 2026Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomarker in Ovarian Cancer After Neoadjuvant chemotherapy (opens in a new tab)Eur J Surg Oncol
- 2025HIPEC in recurrent ovarian cancer: flogging a tired HORSE? (opens in a new tab)J Gynecol Oncol
- 2025The CHIPOR trial-sufficient evidence to use hyperthermic intraperitoneal chemotherapy in routine care for recurrent ovarian cancer? (opens in a new tab)Int J Gynecol Cancer
- 2024The Significance of the Morphological Appearance of Peritoneal Lesions on Imaging in Patients With Peritoneal Malignancies-A Report From Phase 1 of the PRECINCT Study (opens in a new tab)J Surg Oncol
- 2024Impact of Previous Abdominal Surgery and Timing of Peritoneal Metastases on Accuracy of Imaging in Predicting the Surgical PCI: A Report From the PRECINCT Study (opens in a new tab)J Surg Oncol
- 2024It's Not Just What Surgeons See, But How They Interpret It (opens in a new tab)Ann Surg Oncol
- 2024Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients (opens in a new tab)Ann Surg Oncol
- 2024Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study (opens in a new tab)J Gynecol Oncol
- 2023Cytoreductive Surgery With or Without HIPEC in the Management of Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer - a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2023Bilateral Thoracic Cytoreductive Surgery for Pseudomyxoma Peritonei of Appendiceal Origin (opens in a new tab)Indian J Surg Oncol
- 2023Paul Sugarbaker and Peritoneal Surface Oncology in India (opens in a new tab)Indian J Surg Oncol
- 2023A Descriptive Analysis of Patients Undergoing Cytoreductive Surgery for the First Peritoneal Recurrence from Adult Granulosa Cell Tumours: Focus on Disease Distribution, Morphology of Peritoneal Disease and the Role of HIPEC - a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2023Very Rare Peritoneal Surface Malignancies (opens in a new tab)Indian J Surg Oncol
- 2023Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies-A report from the Indian HIPEC Registry (opens in a new tab)Indian J Surg Oncol
- 2022Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer (opens in a new tab)Front Oncol
- 2022Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies-a Retrospective Bi-institutional Study (opens in a new tab)Indian J Surg Oncol
- 2022Perspectives on Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer (opens in a new tab)JAMA Surg
- 2022Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial" (opens in a new tab)Int J Cancer
- 2022New Insights on the Treatment of Colorectal Peritoneal Metastases From the CAIRO6 Trial (opens in a new tab)JAMA Surg
- 2021Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey (opens in a new tab)Pleura Peritoneum
- 2021Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study (opens in a new tab)BMJ Open
- 2021Greater-omentum lesion-score (GOLS) as a predictor of residual disease in different regions of the peritoneal cavity in patients undergoing interval cytoreductive surgery for advanced ovarian cancer and its potential clinical utility (opens in a new tab)Eur J Surg Oncol
- 2021Limitations of the PRODIGE 7 trial (opens in a new tab)Lancet Oncol
- 2021Total parietal peritonectomy performed during interval cytoreductive surgery for advanced epithelial serous ovarian cancer results in a low incidence of platinum resistant recurrence- results of a prospective multi-centre study (opens in a new tab)Eur J Surg Oncol
- 2021Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer (opens in a new tab)Eur J Surg Oncol
- 2021Implications of Pathologic Findings in Cytoreductive Surgery Specimens on Treatment of Colorectal Peritoneal Metastases: Results of a Prospective Multicentric Study (opens in a new tab)Dis Colon Rectum
- 2021Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study (opens in a new tab)Ann Surg Oncol
- 2021Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications (opens in a new tab)Eur J Surg Oncol
- 2021Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Patients with Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study (opens in a new tab)Ann Surg Oncol
- 2021A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer - A study by INDEPSO (opens in a new tab)Eur J Surg Oncol
- 2020Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index (opens in a new tab)Colorectal Dis
- 2020Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications (opens in a new tab)Eur J Surg Oncol
- 2020The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors (opens in a new tab)Ann Surg Oncol
- 2020Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease? (opens in a new tab)Eur J Surg Oncol
- 2019Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study (opens in a new tab)Eur J Surg Oncol
- 2019Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study (opens in a new tab)Indian J Surg Oncol
- 2019Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Initial Experience from Indian Centers and a Review of Literature (opens in a new tab)Indian J Surg Oncol
- 2019Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Malignancies-Experience from Indian Centers (opens in a new tab)Indian J Surg Oncol
- 2019Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication-a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC-a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO (opens in a new tab)Indian J Surg Oncol
- 2019The Current Status of Peritoneal Surface Oncology in India (opens in a new tab)Indian J Surg Oncol
- 2019Preface 'Changing Trend in Peritoneal Surface Oncology in Asian Countries' (opens in a new tab)Indian J Surg Oncol
- 2019Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO) (opens in a new tab)Eur J Surg Oncol
- 2019Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study (opens in a new tab)Colorectal Dis
- 2018Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry (opens in a new tab)Int J Hyperthermia
- 2018Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification (opens in a new tab)Eur J Surg Oncol
- 2017The "homemade" HIPEC machine - a cost-effective alternative in low-resource countries (opens in a new tab)Pleura Peritoneum
- 2017CRS and HIPEC for PMP-Use of the LC-CUSUM to Determine the Number of Procedures Required to Attain a Minimal Level of Proficiency in Delivering the Combined Modality Treatment (opens in a new tab)Indian J Surg Oncol
- 2017Setting up of the Indian HIPEC Registry: A Registry for Indian Patients with Peritoneal Surface Malignancies (opens in a new tab)Indian J Surg Oncol
- 2017Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: A preliminary five-year experience (opens in a new tab)J BUON
- 2016The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases (opens in a new tab)Indian J Surg Oncol
Co-authored
- 2026Comparative oncological efficacy of chemotherapy, cytoreductive surgery with or without HIPEC in recurrent ovarian cancer: A network meta-analysis (opens in a new tab)Eur J Surg Oncol
- 2026Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows (opens in a new tab)Int J Gynecol Cancer
- 2026Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging discipline (opens in a new tab)Eur J Surg Oncol
- 2025Development of a history-taking form for mesothelioma patients at risk of exposure to asbestos (opens in a new tab)Public Health Action
- 2025Peritoneal surface malignancy: performing complete cytoreduction in occult peritoneal spaces is challenging (opens in a new tab)Br J Surg
- 2025Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status: An International Survey of Peritoneal Surface Malignancy Surgeons (opens in a new tab)Ann Surg Oncol
- 2023Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal Malignancy Centre (opens in a new tab)Indian J Surg Oncol
- 2023Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients (opens in a new tab)Front Oncol
- 2023High-Risk Peritoneal Mesothelioma: Does Metronomic Chemotherapy Have a Role? (opens in a new tab)Indian J Surg Oncol
- 2023Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer (opens in a new tab)Ann Surg Oncol
- 2022Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study (opens in a new tab)Eur J Surg Oncol
- 2021The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI (opens in a new tab)Cancers (Basel)
- 2020Comparing Technical Feasibility of Non-robotic Retroauricular Versus Transcervical Approach Neck Dissection in Oral Cancers-a Preliminary Single Institute Experience (opens in a new tab)Indian J Surg Oncol
- 2019Correlation Between Pelvic Peritoneal Disease and Nodal Metastasis in Advanced Ovarian Cancer: Can Intraoperative Findings Define the Need for Systematic Nodal Dissection? (opens in a new tab)Indian J Surg Oncol
- 2017A Rare Case of Adenoma Malignum: Preparing for the Unforeseen (opens in a new tab)J Obstet Gynaecol India
- 2016Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy (opens in a new tab)Indian J Surg Oncol
Awards & Leadership
- Top Reviewer AwardEuropean Journal of Surgical Oncology · 2023
- Peritoneal Surface Oncology Group International (PSOGI)Executive committee member · 2021
- Society of Peritoneal Surface Oncology of India (SPSOi)Honorary Secretary · 2017
- Indian Network for Development of Peritoneal Surface Oncology (INDEPSO)President
- Surgical Oncology (Elsevier journal)Editor-in-chief